Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Ana
For intermediate-stage HCC beyond up-to-seven criteria, the integration of TACE and HAIC plus lenvatinib therapy demonstrated substantial enhancements in survival prognosis, which is a promising treatment regimen.
Authors
- Fengtao Zhang (ORCID: https://orcid.org/0009-0003-7128-0126)
- Qiming Wei
- Sheng Zhong (ORCID: https://orcid.org/0000-0002-1620-2059)
- Quan Zeng
- Honglei Hu (ORCID: https://orcid.org/0009-0007-1371-567X)
- Yangyang Li (ORCID: https://orcid.org/0000-0001-8136-9130)
- Haiming Zhang (ORCID: https://orcid.org/0000-0002-0746-1147)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Chinese Academy of Sciences (CN)
- Tung Wah Hospital (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- ShenZhen People’s Hospital (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Dongguan People’s Hospital (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- First Affiliated Hospital of Jinan University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-02-28
- DOI
- https://doi.org/10.2147/jhc.s506457
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32